FDA recall record

RemedyRepack Valsartan 160 mg Tablets, HDPE 90 cc bottles in cardboard trays recall — FDA D-1101-2018

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIclassification
D-1101-2018official record ID
Aug 22, 2018report date

Recall record at a glance

Official recordD-1101-2018
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmRemedyRepack Inc.
Report dateAug 22, 2018
Recall initiation dateAug 10, 2018
Quantity21 bottles of 90 = 1890 tablets
LocationIndiana, PA, United States

Official product description

Valsartan 160 mg Tablets, HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 Kolter Drive, Suite 4, Indiana, PA 15701, NDC: 61786-0792-19

Why the product was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Distribution information

Product was distributed to three customers in FL and VA.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.